Joshua Reed
Director of Finance/CFO bij OMEGA THERAPEUTICS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Joshua Reed is an Independent Director at Scholar Rock Holding Corp.
and the Chief Financial & Accounting Officer at Omega Therapeutics, Inc. He was previously the Vice President & Head-Finance Operations at Bristol Myers Squibb Co. from 2016 to 2018, Vice President-Strategic Business Development at JPMorgan Chase & Co. from 2002 to 2005, and the Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2018 to 2022.
Reed received his undergraduate degree from Rutgers State University of New Jersey and his MBA from Stephen M.
Ross School of Business.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
21-06-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Joshua Reed
Bedrijven | Functie | Begin |
---|---|---|
SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 18-03-2021 |
OMEGA THERAPEUTICS, INC. | Director of Finance/CFO | 23-05-2022 |
Eerdere bekende functies van Joshua Reed
Bedrijven | Functie | Einde |
---|---|---|
ALDEYRA THERAPEUTICS, INC. | Director of Finance/CFO | 10-05-2022 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-07-2018 |
JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01-01-2005 |
Opleiding van Joshua Reed
Rutgers State University of New Jersey | Undergraduate Degree |
Stephen M. Ross School of Business | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
JPMORGAN CHASE & CO. | Finance |
ALDEYRA THERAPEUTICS, INC. | Health Technology |
SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
OMEGA THERAPEUTICS, INC. | Health Technology |